This page gives details of the analysts who write research on Evgen Pharma.
It also gives access to the research on the company written by Hardman & Co.
|Northland Capital Partners||Vadim Alexandre|
|Hardman & Co||Martin Hall|
|Hardman & Co||11th December 2017||Interims - increased funding to the end of Phase II trials||Download Research|
|Hardman & Co||21st June 2017||Clinical trials update||Download Research|
|Hardman & Co||14th December 2016||Interims - update on clinical progress||Download Research|
|Hardman & Co||29th November 2016||Harnessing the clinical potential of sulforaphane||Download Research|